To include your compound in the COVID-19 Resource Center, submit it here.

Trp-ing up cancer cells

Calcium channel blockers have been used for some time to target neurological and cardiovascular diseases, based on the potent role played by intracellular calcium (Ca2+) in signaling neurotransmission and muscular contraction. However, Dendreon Corp. has identified a trans-membrane voltage-gated calcium channel gene that is expressed on certain tumors, providing a new cancer target of sufficient interest to get Genentech Inc. on board as a partner.

DNDN (Seattle,

Read the full 677 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers